Related Experiment Video
Updated: Jul 16, 2026

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
TRPA1 and issues relating to animal model selection for extrapolating toxicity data to humans
1Chemical, Biological and Radiological (CBR) Division, Defence Science and Technology Laboratory (Dstl), Salisbury, UK.
Abstract:
The transient receptor potential ankyrin 1 (TRPA1) ion channel is a sensor for irritant chemicals, has ancient lineage, and is distributed across animal species including humans, where it features in many organs. Its activation by a diverse panel of electrophilic molecules (TRPA1 agonists) through electrostatic binding and/or covalent attachment to the protein causes the sensation of pain. This article reviews the species differences between TRPA1 channels and their responses, to assess the suitability of different animals to model the effects of TRPA1-activating electrophiles in humans, referring to common TRPA1 activators (exogenous and endogenous) and possible mechanisms of action relating to their toxicology. It concludes that close matching of in vitro and in vivo models will help optimise the identification of relevant biochemical and physiological responses to benchmark the efficacy of potential therapeutic drugs, including TRPA1 antagonists, to counter the toxic effects of those electrophiles capable of harming humans. The analysis of the species issue provided should aid the development of medical treatments to counter poisoning by such chemicals.
Insights
Transient receptor potential ankyrin 1 (TRPA1) channels sense irritants and cause pain. Understanding species differences in TRPA1 responses is crucial for developing effective human therapies against chemical toxins.
Area of Science:
- Neuroscience
- Toxicology
- Molecular Biology
Background:
- The transient receptor potential ankyrin 1 (TRPA1) ion channel functions as a sensor for irritant chemicals across numerous animal species, including humans.
- TRPA1 activation by electrophilic molecules, known as TRPA1 agonists, leads to the sensation of pain through binding interactions with the protein.
Purpose of the Study:
- To review species differences in TRPA1 channels and their responses.
- To evaluate the suitability of animal models for studying TRPA1-activating electrophiles in humans.
- To inform the development of medical treatments for chemical poisoning.
Main Methods:
- Review of existing literature on TRPA1 channel function and species variations.
- Analysis of common exogenous and endogenous TRPA1 activators.
- Examination of mechanisms of action and toxicological relevance.
Main Results:
- Significant species-specific differences exist in TRPA1 channel structure and function.
- Various electrophiles activate TRPA1 channels through distinct binding and covalent mechanisms.
- Animal models exhibit varying degrees of similarity to human TRPA1 responses.
Conclusions:
- Close alignment of in vitro and in vivo models is essential for identifying relevant biochemical and physiological responses.
- Optimized models will aid in benchmarking the efficacy of TRPA1 antagonists for treating electrophile toxicity.
- This analysis provides a foundation for developing better medical countermeasures against harmful chemicals.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Toxicokinetics: Overview
Toxicity Testing in Animals

